Department of Internal Medicine, Detroit Medical Center, Wayne State University, Detroit, Michigan, United States of America.
Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota, United States of America.
PLoS One. 2021 Sep 16;16(9):e0255981. doi: 10.1371/journal.pone.0255981. eCollection 2021.
Hospitalization of patients infected with the severe acute respiratory syndrome virus 2 (SARS-CoV-2) have remained considerable worldwide. Patients often develop severe complications and have high mortality rates. The cycle threshold (Ct) value derived from nasopharyngeal swab samples using real time polymerase chain reaction (RT-PCR) may be a useful prognostic marker in hospitalized patients with SARS-CoV-2 infection, however, its role in predicting the course of the pandemic has not been evaluated thus far.
We conducted a retrospective cohort study which included all patients who had a nasopharyngeal sample positive for SARS-CoV-2 between April 4 -June 5, 2020. The Ct value was used to estimate the number of viral particles in a patient sample. The trend in initial viral load on admission on a population level was evaluated. Moreover, patient characteristics and outcomes stratified by viral load categories were compared and initial viral load was assessed as an independent predictor of intubation and in-hospital mortality.
A total of 461 hospitalized patients met the inclusion criteria. This study consisted predominantly of acutely infected patients with a median of 4 days since symptom onset to PCR. As the severity of the pandemic eased, there was an increase in the percentage of samples in the low initial viral load category, coinciding with a decrease in deaths. Compared to an initial low viral load, a high initial viral load was an independent predictor of in-hospital mortality (OR 5.5, CI 3.1-9.7, p < 0.001) and intubation (OR 1.82 CI 1.07-3.11, p = 0.03), while an initial intermediate viral load was associated with increased risk of inpatient mortality (OR 1.9, CI 1.14-3.21, p = 0.015) but not with increased risk for intubation.
The Ct value obtained from nasopharyngeal samples of hospitalized patients on admission may serve as a prognostic marker at an individual level and may help predict the course of the pandemic when evaluated at a population level.
全球范围内,感染严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的患者住院治疗的情况仍然很多。这些患者常出现严重并发症,死亡率较高。实时聚合酶链反应(RT-PCR)检测鼻咽拭子样本的循环阈值(Ct)值可能是 SARS-CoV-2 感染住院患者的一种有用的预后标志物,但迄今为止,尚未评估其在预测大流行进程中的作用。
我们进行了一项回顾性队列研究,纳入了 2020 年 4 月 4 日至 6 月 5 日期间鼻咽拭子 SARS-CoV-2 检测阳性的所有患者。Ct 值用于估计患者样本中的病毒颗粒数量。评估人群水平上入院时初始病毒载量的变化趋势。此外,比较了按病毒载量分类的患者特征和结局,并将初始病毒载量评估为插管和住院死亡率的独立预测因子。
共纳入 461 例符合条件的住院患者。本研究主要为急性感染患者,从症状出现到 PCR 检测的中位数为 4 天。随着大流行的严重程度缓解,低初始病毒载量样本的比例增加,与死亡率降低一致。与初始低病毒载量相比,初始高病毒载量是住院死亡率(OR 5.5,95%CI 3.1-9.7,p<0.001)和插管(OR 1.82,95%CI 1.07-3.11,p=0.03)的独立预测因子,而初始中等病毒载量与住院死亡率增加相关(OR 1.9,95%CI 1.14-3.21,p=0.015),但与插管风险增加无关。
入院时从住院患者鼻咽样本中获得的 Ct 值可作为个体水平的预后标志物,在人群水平评估时可帮助预测大流行进程。